Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2024-12-16 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
北京植德律师事务所关于西藏易明西雅医药科技股份有限公司2024年限制性股票激励计划的法律意见书
Remuneration Information Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a 2024 restricted stock incentive plan for a listed company, 西藏易明西雅医药科技股份有限公司. It extensively discusses the legal compliance, procedures, eligibility, stock quantities, pricing, vesting conditions, and other regulatory requirements related to the stock incentive plan. The document is not a financial report, earnings release, or a simple announcement. It is a legal opinion specifically about a stock incentive plan, which is a form of remuneration information related to executive and employee compensation. The document length is substantial (15,000 characters), and it contains detailed substantive content rather than just an announcement or certification. Therefore, the most appropriate classification is Remuneration Information (DEF 14A), which covers reports detailing compensation plans for executives and directors, including stock incentive plans.
2024-12-16 Chinese
关于召开2025年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about convening the 2025 first extraordinary general meeting (临时股东大会) of shareholders for a company, including meeting time, voting methods (onsite and online), agenda items, registration procedures, and proxy forms. It does not contain financial statements or results but is an official announcement to shareholders about the meeting and voting process. The document length is 4067 characters, which is relatively short and consistent with a meeting notice rather than a full report. There is no indication of financial data or management discussion. This fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-12-16 Chinese
易明医药：2024年限制性股票激励计划（草案）摘要
Remuneration Information Classification · 95% confidence The document is a detailed summary of a 2024 restricted stock incentive plan (draft) for a company, including legal references, plan purpose, management structure, eligibility criteria, stock quantities, pricing, vesting conditions, performance targets, and governance procedures. It is a comprehensive plan document related to executive and employee stock incentives, not a financial report, earnings release, or regulatory announcement. It does not fit categories like Annual Report, Earnings Release, or Call Transcript. It is not a simple announcement or certification but a substantive plan document. The content aligns with disclosures about executive compensation and stock incentive plans, which are typically classified under Remuneration Information filings. Therefore, the best fitting category is Remuneration Information (DEF 14A). Confidence is high given the detailed nature and focus on stock incentive plan terms and governance.
2024-12-16 Chinese
2024年限制性股票激励计划首次授予激励对象名单
Remuneration Information Classification · 95% confidence The document is titled as a list of recipients for a 2024 restricted stock incentive plan from a company. It details the names, positions, and stock quantities allocated to various management and core personnel. There is no indication of financial statements, audit information, or regulatory filings. The content focuses on stock incentive allocations to management and employees, which is related to remuneration or compensation information. Given the nature of the document as a detailed list of stock incentives granted to executives and key personnel, it fits best under Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2024-12-16 Chinese
易明医药：2024年限制性股票激励计划实施考核管理办法
Governance Information Classification · 95% confidence The document is titled as an implementation and assessment management method for a 2024 restricted stock incentive plan by the company. It details the governance, assessment criteria, performance targets, and procedures related to the stock incentive plan. It is a regulatory or governance-related document focusing on internal rules and incentive mechanisms rather than financial results, earnings, or shareholder meeting materials. It does not contain financial statements or earnings data, nor is it a report publication announcement. The content aligns with governance practices and internal company policy documentation related to stock incentives and management structure. Therefore, the most appropriate classification is Governance Information (CGR). The document length is under 5,000 characters, but it is not merely an announcement of a report; it is the actual policy document itself.
2024-12-16 Chinese
第三届监事会第十九次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of a company regarding approval of proposals related to a 2024 restricted stock incentive plan. It details the meeting date, attendance, voting results, and legal compliance statements. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It is an official announcement of board/management decisions related to governance and incentive plans. This fits best under Board/Management Information (MANG) as it announces decisions made by the supervisory board and management regarding company governance matters.
2024-12-16 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.